Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Viral Load
100%
Host Transcriptional Response
100%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
100%
Host Response
50%
Interferon-α (IFN-α)
33%
Antiviral Response
33%
Responsive Genes
33%
T Helper 1
33%
Chemokine CXCL9
33%
Ribosomal Proteins
33%
Humoral Immune Response
16%
Wound Healing
16%
Antiviral Factor
16%
Viral Infection
16%
Gene Expression
16%
Age of Infection
16%
Patient Demographics
16%
RNA Sequencing (RNA-seq)
16%
Cognate Receptors
16%
Chemokines
16%
Neutrophils
16%
Clinical Manifestations
16%
Disease Severity
16%
Angiotensin-converting Enzyme 2 (ACE2)
16%
CXCR3
16%
Natural Killer Cells
16%
Post-infection
16%
Reduced Expression
16%
Genetic Diversity
16%
Negative Control
16%
Patient Matched
16%
Natural Killer
16%
Granzyme B
16%
Low Viral Load
16%
Human Airways
16%
Nasopharyngeal Swab
16%
Cytotoxic T Cells
16%
Gunshot
16%
Elapsed Time
16%
OAS1
16%
IFITM3
16%
Nuclear factor-κB Pathway
16%
CD8A
16%
Airway Epithelial Cultures
16%
Load Time
16%
Interferon-stimulated Genes
16%
Infection Status
16%
Older Individuals
16%
Immunology and Microbiology
Viral Load
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Immune Response
50%
Infectious Disease
50%
Infection
50%
interferon
33%
CXCL9 Chemokine
33%
Humoral Immunity
16%
Upregulation
16%
Interferon-Stimulated Gene
16%
Gene Expression
16%
Chemokine
16%
Immunoglobulin Enhancer Binding Protein
16%
Wound Healing
16%
Neutrophil
16%
Cytotoxic T Cell
16%
Chemokine Receptor CXCR3
16%
RNA Sequence
16%
Natural Killer Cell
16%
Granzyme B
16%
Airway
16%
CD8A
16%